GN0M.DE vs. QYLE.DE

Last updated Jun 5, 2026

GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and QYLE.DE (Global X Nasdaq 100 Covered Call UCITS ETF D) are both exchange-traded funds - GN0M.DE is a Health & Biotech Equities fund tracking the Solactive Genomics, while QYLE.DE is a Nasdaq-100 fund tracking the Cboe Nasdaq-100 BuyWrite. Both are passively managed. Over the past 3 years, GN0M.DE returned -1.90%/yr vs 12.74%/yr for QYLE.DE. At a 0.32 correlation, their price movements are largely independent. GN0M.DE charges 0.50%/yr vs 0.45%/yr for QYLE.DE.

Performance

GN0M.DE vs. QYLE.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Global X Nasdaq 100 Covered Call UCITS ETF D (QYLE.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than QYLE.DE's 6.53% return.

GN0M.DE

• 1D: 5.61%
• 1M: 11.50%
• YTD: 12.99%
• 6M: 9.82%
• 1Y: 55.73%
• 3Y*: -1.90%
• 5Y*: —
• 10Y*: —

QYLE.DE

• 1D: -1.00%
• 1M: 2.58%
• YTD: 6.53%
• 6M: 7.45%
• 1Y: 16.40%
• 3Y*: 12.74%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GN0M.DE vs. QYLE.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
GN0M.DE Global X Genomics & Biotechnology UCITS ETF	12.99%	5.67%	-12.40%	-9.04%	-6.92%
QYLE.DE Global X Nasdaq 100 Covered Call UCITS ETF D	6.53%	-7.62%	37.36%	30.02%	-5.59%

Correlation

The correlation between GN0M.DE and QYLE.DE is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.33
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (All Time) Calculated using the full available price history since Nov 24, 2022	0.32

Return for Risk

GN0M.DE vs. QYLE.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE

GN0M.DE Risk / Return Rank: 58
GN0M.DE Sharpe Ratio Rank: 60
GN0M.DE Sortino Ratio Rank: 61
GN0M.DE Omega Ratio Rank: 54
GN0M.DE Calmar Ratio Rank: 68
GN0M.DE Martin Ratio Rank: 50

QYLE.DE

QYLE.DE Risk / Return Rank: 57
QYLE.DE Sharpe Ratio Rank: 50
QYLE.DE Sortino Ratio Rank: 49
QYLE.DE Omega Ratio Rank: 49
QYLE.DE Calmar Ratio Rank: 78
QYLE.DE Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. QYLE.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Global X Nasdaq 100 Covered Call UCITS ETF D (QYLE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GN0M.DE	QYLE.DE	Difference
Sharpe ratio: Return per unit of total volatility	2.00	1.68	+0.32
Sortino ratio: Return per unit of downside risk	2.82	2.35	+0.47
Omega ratio: Gain probability vs. loss probability	1.33	1.30	+0.03
Calmar ratio: Return relative to maximum drawdown	3.32	3.87	-0.55
Martin ratio: Return relative to average drawdown	8.35	10.46	-2.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GN0M.DE vs. QYLE.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 2.00, which is comparable to the QYLE.DE Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of GN0M.DE and QYLE.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GN0M.DE	QYLE.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.00	1.68	+0.32
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	1.16	-1.50

Drawdowns

GN0M.DE vs. QYLE.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than QYLE.DE's maximum drawdown of -24.06%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and QYLE.DE.

Drawdown Indicators

	GN0M.DE	QYLE.DE	Difference
Max Drawdown Largest peak-to-trough decline	-67.19%	-24.06%	-43.13%
Max Drawdown (1Y) Largest decline over 1 year	-16.68%	-4.17%	-12.51%
Max Drawdown (3Y) Largest decline over 3 years	-48.19%	-24.06%	-24.13%
Current Drawdown Current decline from peak	-41.03%	-5.04%	-35.99%
Average Drawdown Average peak-to-trough decline	-43.13%	-5.68%	-37.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.65%	1.55%	+5.10%

Volatility

GN0M.DE vs. QYLE.DE - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to Global X Nasdaq 100 Covered Call UCITS ETF D (QYLE.DE) at 2.32%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than QYLE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GN0M.DE	QYLE.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.15%	2.32%	+5.83%
Volatility (6M) Calculated over the trailing 6-month period	19.69%	6.14%	+13.55%
Volatility (1Y) Calculated over the trailing 1-year period	27.68%	9.63%	+18.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.49%	13.25%	+18.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.49%	13.25%	+18.24%

GN0M.DE vs. QYLE.DE - Expense Ratio Comparison

GN0M.DE has a 0.50% expense ratio, which is higher than QYLE.DE's 0.45% expense ratio.

Dividends

GN0M.DE vs. QYLE.DE - Dividend Comparison

GN0M.DE has not paid dividends to shareholders, while QYLE.DE's dividend yield for the trailing twelve months is around 8.84%.

Position	TTM	2025	2024	2023
GN0M.DE Global X Genomics & Biotechnology UCITS ETF	0.00%	0.00%	0.00%	0.00%
QYLE.DE Global X Nasdaq 100 Covered Call UCITS ETF D	8.84%	10.67%	15.00%	20.20%

Frequently Asked Questions

Can I hold both GN0M.DE and QYLE.DE in my portfolio?

GN0M.DE and QYLE.DE have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, GN0M.DE or QYLE.DE?

On fees, QYLE.DE is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, GN0M.DE or QYLE.DE?

QYLE.DE is cheaper with a 0.45% expense ratio, compared with 0.50% for GN0M.DE.

What is the main difference between GN0M.DE and QYLE.DE?

GN0M.DE is categorized as Health & Biotech Equities, while QYLE.DE is Nasdaq-100. GN0M.DE tracks Solactive Genomics, while QYLE.DE tracks Cboe Nasdaq-100 BuyWrite. Their fees differ too: 0.50% for GN0M.DE and 0.45% for QYLE.DE.